DOI QR코드

DOI QR Code

청상사화탕(淸上瀉火湯)이 토끼의 수축혈관에 미치는 영향

Effects of ChungSangSaWhaTang on The Arteral Contraction in Rabbit

  • 전성배 (세명대학교 한의과대학 내과학교실) ;
  • 김이화 (세명대학교 한의과대학 경혈학교실) ;
  • 남창규 (세명대학교 한의과대학 내과학교실)
  • Jeon, Sung-Bai (Dept. of Internal Medicine, College of Oriental Medicine, Semyung Univ.) ;
  • Kim, Ee-Hwa (Dept. of Meridian & Acupoint, College of Oriental Medicine, Semyung Univ.) ;
  • Nam, Chang-Gyu (Dept. of Internal Medicine, College of Oriental Medicine, Semyung Univ.)
  • 발행 : 2003.12.30

초록

This study was undertaken to define the effect of ChungSangSaWhaTang on the norepinephrine-induced arterial contraction and the mechanism of ChungSangSaWhaTang-induced relaxation. In order to investigate the effect of ChungSangSaWhaTang on contracted rabbit carotid arterial strips, transverse strips with intact or damaged endothelium were used for the experiment using organ bath. To analyze the mechanism of ChungSangSaWhaTang-induced relaxation, ChungSangSaWhaTang extract infused into contracted arterial strips induced by norepinephrine after treatment of indomethacin, $N_{\omega}$-nitro-L-arginine, or tetraethylammonium chloride. ChungSangSaWhaTang relax arterial strip with endothelium contracted by norepinephrine, but in the strips without endothelium, ChungSangSaWhaTang-induced relaxation was significantly inhibited. The endothelium-dependent relaxation induced by ChungSangSaWhaTang was decreased by the pretreatment of $N_{\omega}$-nitro-L-arginine, but it was not observed in the strips pretreated with indomethacin or tetraethylammonium chloride. We suggest that ChungSangSaWhaTang may inhibit agonist-induced contraction through the formation of nitric oxide in the vascular endothelial cells.

참고문헌

  1. Carretero, O. A., Oparil, S., Circulation. Essential Hypertension : Part I : Definition and Etiology. 2000, Circulation, 101, 329–335.
  2. 李星勳, 全燦鎔, 朴鐘榮, 腦卒中患者 226例에 對한 臨床的 考察, 大韓韓醫學會誌 1997, 18(1) : 5–24.
  3. 서울대학교 의과대학, 심장학, 서울, 서울대학교 출판부, 1987, pp. 207-211.
  4. Gross, F., Robertson, J. I. S., Arterial Hypertension. G. K. Hall & Co., 1980, 5 : 1–6.
  5. Levi, R., Therapies for perioperative hypertension : Pharmacodynamic considerations, Acta Anaesthesiol. Scand. Suppl., 1993, 37(99) 16–19.
  6. 金完熙, 高血壓治療의 辨證에 關한 硏究. 大韓韓醫學會誌 1982, 3(2) : 3–13.
  7. 楊維傑, 黃帝內經素問譯解, 서울, 成輔社, 1980, p. 96, 633, 662, 663.
  8. 張隱庵, 黃帝內經素問集注, 上海, 上海科學技術出版社, 1991. p. 4.
  9. 黃度淵, 對譯證脈方藥合編, 南山堂, 서울, 1985, pp. 232-233.
  10. 許浚, 東醫寶鑑, 法人文化社, 서울, 2002, p. 501.
  11. 李尙仁, 本草學, 圖書出版 修書院, 서울, 1981, pp.192-193, 195-196, 198-202, 207-208, 221-222, 228-231, 481-483, 501-509.
  12. 송효정, 문준전, 청상사화탕이 혈압 및 지질대사에 미치는 영향, 경희대논문집 1982, 5 : 131-146.
  13. 何紹奇, 現代中醫內科學, 北京, 中國醫藥科技出版社, 1991, pp. 263-268.
  14. 金完熙, 崔達永, 臟腑辨證論治, 서울, 成輔社, 1985, p. 139, 140.
  15. Vanhoutte, P. M., Houston, D. S., Platelets and vascular occlusion, Platelets, endothelium, and vasospasm, Circulation 1985 ; 72(4) : 728–734.
  16. Vanhoutte, P. M., Rubanyi, G. M., Miller, V. M., Houston D. S., Modulation of vascular smooth muscle contraction by the endothelium. Ann. Rev. Physiol., 1986 ; 48 : 307–320. https://doi.org/10.1146/annurev.ph.48.030186.001515
  17. Feletou, M., Vanhoutte, P. M., Endothelium-dependent hyperpolarization of canine coronary smooth muscle. Br. J. Pharmacol., 1988 ; 93 : 515–524.
  18. Suzuki, H., Chen, G., Yamamoto, Y., Miwa, K., Nitroarginine-sensitive and -insensitive components of the endothelium-dependent relaxation in the guinea-pig carotid artery. Jpn. J. Physiol., 1992 ; 42(2) : 335–347.
  19. Feletou, M., Girard, V., Canet, E., Different Involvement of Nitro Oxide in Endothelium-Dependent Relaxation of Porcine Pulmonary Artery and Vein : Influence of Hypoxia. J. of Cardiovascular Pharmacology, 1995 ; 25 : 665–673.
  20. Hecker, M., Endothelium-derived hyperpolarzing factor - fact or fiction?. News Physiol. Sci., 2000 ; 15 : 1–5.
  21. Yokota, Y., Imaizumi, Y., Ansano, M., Matsuda, T., Watanabe, M., Endothelium-derived relaxing factor releaved by 5-HT : distinct from nitric oxide in basilar arteries of normotensive and hypertensive rats. Br. J. Pharmacol., 1994 ; 11 : 24–330.
  22. Johns, R. A., Endothelium-derived relaxing factor ; Basic review and clinical implications. J. Cardiothorac. Vasc. Anesth., 1991 ; 5(1) : 69–79.
  23. Palmer, R. M. J., Ferrige, A. G., Moncada, S., Nitric oxide release accounts for the biological activity of endothelium-derived relaxing factor. Nature, 1987 ; 327 : 524–526. https://doi.org/10.1038/327524a0
  24. Palmer, R. M., Rees, D. D., Ashton, D. S., Moncada, S., L-arginine is the physiological precursor for the formation of nitric oxide in endothelium-dependent relaxation. Biochem. Biophys. Res. Commun., 1988 ; 153(3) : 1251–1256. https://doi.org/10.1016/S0006-291X(88)81362-7
  25. Moore, P. K., al-Swayeh, O. A., Chong N. W. S., Evans R. A., Gibson A., $_L-N^G$-nitro arginine $(_L-NOARG)$, a novel, L-arginine-reversible inhibitor of endothelium-dependent vasodilatation in vitro. Br. J. Pharmacol., 1990 ; 99 : 408–412.
  26. Nandor, M., Una, S. R., John, D. C., Endothelial cGMP does not regulate basal release of endothelium-derived relaxing factor in culture. Am. J. Physiol., 1992 ; 263 : L113–L121.